Abhishek Shukla

Abhishek Shukla

Auto-generated profile, based on publicly available information

Abhishek Shukla

Department of Geriatric Medicine and Palliative Care, Aastha Geriatric Hospital and Hospice Care Centre, Lucknow, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2024 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
AJAstha Jaiswal
Astha Jaiswal
ASAbhishek Shukla
Abhishek Shukla
ACAnupsinh H Chhasatia
Anupsinh H Chhasatia
SSSonia Sharma
Sonia Sharma
PKPrakriti Kapoor
Prakriti Kapoor
DCDevraj Singh Chouhan
Devraj Singh Chouhan
One of the most difficult conditions to treat while dealing with post-stroke aphasia and depression is related. To help stroke survivors manage their depression symptoms, stroke medical professionals are essential. In light of stroke specialists' opinions about post-stroke aphasia, this study intends to investigate current methods of treating depression. In five semi-structured focus groups, thirty-nine stroke healthcare professionals from various phases of stroke therapy took part. A thorough transcript analysis of these focus group talks was conducted using the interpretive description approach. After the transcripts were analyzed, several themes emerged, including the difficulties associated with treating depression and aphasia at the same time in stroke rehabilitation, the undervaluing of mood disorders in clinical practice, the use of ad hoc methods for diagnosis and treatment, and the attempts of stroke doctors to fill in the gaps in psychological care. This study emphasizes how difficult it is for doctors to treat depression in patients who have had a stroke-related aphasia. For better patient care, evidence-based therapies are crucial, as is the inclusion of mental health services in stroke rehabilitation. Policies that promote mental health should be developed, leaders should take the lead in putting comprehensive treatment plans into practice, and healthcare professionals should get specialized training. These initiatives have a critical role in enhancing the results and standard of life for those coping with the co-occurring conditions of depression and aphasia after stroke.

15 August 2023 in Annals of Geriatric Education and Medical Sciences
Verified
Journal Article
Open access
PDF file
ASAbhishek Shukla
Abhishek Shukla
ASAmita Shukla
Amita Shukla
PMPankhuri Misra
Pankhuri Misra
: Dementia and cognitive impairment (CI) are some of the common problems associated with ageing. However, a lot of other factors apart from ageing can increase this risk. In this study, prevalence of CI and its correlation with different sociodemographic and clinical factors was assessed among patients attending outpatient department of a geriatric healthcare facility.: A total of 240 elderly OPD patients (>60 years) having recovered from different acute illnesses or making follow-up visits were enrolled in the study. Critically ill, hospitalized patients and those with history of COVID-19 exposure were excluded from the study. Demographic and social profile of the patients was noted. Mini Mental State Examination (MMSE) was used for assessment of cognition. MMSE score <27 was considered as CI. Data was analyzed using chi-square test for univariate and binary logistic regression for multivariate assessment. Mean age of patients was 72.58±6.46 years (range 62-91 years), majority of patients were males (55%). Prevalence of CI was 41.2%. There were 59 (24.6%) elderly with mild and 40 (16.7%) with moderate cognitive impairment. On univariate assessment, older age (p=0.003), male sex (p=0.024), living without spouse (p=0.040) and history of hospitalization in last one year (p=0.031) were found to be significantly associated with CI. On logistic regression age (OR=1.072), female sex (OR=0.561), ability to perform routine work (OR=0.461) and hospitalization history (OR=1.823) were identified as independent predictors of CI.: Prevalence of CI was 41.2% in our study. Age, sex, ability to perform routine works and hospitalization history were independently associated with CI risk.

20 May 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
SMSmitha Madhavan
Smitha Madhavan
ASAbhishek Shukla
Abhishek Shukla
GSGujjala Srinath
Gujjala Srinath
BBBharat Bhushan
Bharat Bhushan
AGAnchal Gupta
Anchal Gupta
SRSalini R
Salini R
Cancer is still one of the main reasons people die around the world, and millions of people are dealing with both the sickness and the heavy physical, social, and mental effects that come with it. Survival rates for people with cancer have gone up thanks to progress in treatment, but the quality of life for many patients, especially those in the later stages of the disease, is still a major worry. Palliative care has become an important part of cancer treatment because it helps with all of a patient's complaints, makes them more comfortable, and supports their general health. This essay looks at new ideas in hospice care that are meant to improve the quality of life for cancer patients. It focuses on individual care models, new treatments, and improvements in collaborative care methods. Recent improvements in hospice care have made patient-centered care, which considers each person's tastes, cultural background, and unique needs, even more important. The most important thing that has changed hospice care is the use of technology, especially telemedicine, mobile health apps, and artificial intelligence. These tools make it easier to keep an eye on patients' conditions all the time, talk to their doctors in real time, and handle their care more efficiently. They also allow for individual care plans that adapt to the changing needs of cancer patients. An important part of hospice care is pain management, which has also come a long way. New drug choices, like focused treatments and less invasive delivery methods, have helped to improve pain control. Adding alternative therapies like acupuncture, massage therapy, and music therapy to standard treatments has also been shown to help with complaints like nausea, tiredness, and worry, giving patients a more complete treatment plan. This essay also talks about the value of psychological support and the problems that cancer patients and their families face with their emotional and mental health. Cognitive-behavioural treatment, mindfulness, and coaching are some mental health therapies that have been shown to lower anxiety and improve general emotional well-being.


20 May 2025 in Health Leadership and Quality of Life
Verified
Journal Article
Open access
PDF file
KKKarthikeyan K
Karthikeyan K
ASAbhishek Shukla
Abhishek Shukla
PAPrateek Aggarwal
Prateek Aggarwal
NRNyalam Ramu
Nyalam Ramu
IKIsh Kapila
Ish Kapila
PSParijatham S
Parijatham S
Introduction: Brain cancer patients suffer severe damage and deterioration to their mental and emotional well-being, which leads to various psychosocial concerns such as isolation, hopelessness, and fear. This process of diagnosing and providing treatment generates more such tensions by intruding into the patients’ support mechanisms and management techniques. To investigate the patient’s brain cancer with psychosocial issues during the early stages of treatment. It attempts to identify factors such as psychological, social, and emotional domains that could hinder their overall well-being and response to treatment. Methods: Data was collected from 60 patients with brain cancer using a validated psychometric survey at baseline and follow-up for their psychosocial experiences during initial treatment. In the early stages of their therapy, brain cancer patients have their anxiety levels, depression levels, quality of life, social support, and coping strategies evaluated. The analysis was conducted by using SPSS software, incorporating descriptive statistics, the t-tests for independent samples and multiple linear regressions to evaluate demographic differences and predictors of psychosocial outcomes. Result: The research highlights the influence of demographic characteristics on the mental health of brain cancer patients by revealing considerable psychosocial issues it experienced throughout the early phases of therapy. Conclusion: The results demonstrate the significance of focused intervention strategies to deal with these problems and enhance patient outcomes, which are neutral such as anxiety level- 50%, depression level-40%, quality of life-45%, social support-50% and coping strategies – 55%. The research emphasizes the significant psychological difficulties that patients with brain tumors face during early stages of their therapy.

1 May 2026 in South Asian Journal of Geriatric Medicine, Surgery, Palliative Care & Hospice
Verified
Journal Article
Open access
ASAbhishek Shukla
Abhishek Shukla
RTRamesh Kumar Thukral
Ramesh Kumar Thukral
PNPushkar Nigam
Pushkar Nigam
ARAjit Kumar Roy
Ajit Kumar Roy
AAArjun Arya
Arjun Arya
RHRobert Hoerr
Robert Hoerr
Dementia is the final stage of a neurodegenerative disease characterized by progressive loss of cognitive and daily living skills. The pathological process is associated with the aging process, affecting up to 66% of individuals older than 65. The initial symptoms, which may include memory loss, behavioral alterations, and neuropsychiatric conditions, should be taken seriously by healthcare professionals. It is important to recognize that patients may exhibit these impairments long before the onset of dementia. The primary objective of treatment should be to delay the progression of the disease, as opposed to merely managing symptoms. While pharmacological interventions, including acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists, have demonstrated efficacy in the management of cognitive decline, their utilization is constrained by adverse effects and poor long-term tolerability. A substantial body of evidence suggests that the standardized Ginkgo biloba leaf extract EGb 761 ® may offer a promising alternative. It has been demonstrated to contribute to the symptomatic treatment of age-related cognitive impairment and dementia. In India, Tebokan ® with EGb 761 ® as its active ingredient, is the sole phytopharmaceutical that has been approved for the treatment of brain disorders, including reduced intellectual capacity and alertness, and memory problems. It is recommended as part of a holistic treatment approach, which also addresses the risk factors for dementia, such as hearing loss, hypertension, excessive alcohol consumption, obesity, smoking, depression, loneliness, physical inactivity, and diabetes. Due to its favorable tolerability and safety profile, Tebokan ® is a suitable treatment option for patients in the early stages of the disease.